Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of mouse primary dermal fibroblasts treated with DNA demethylating agent 5-aza-2-deoxycytidine and sorted by X-chromosome-linked GFP expression


ABSTRACT: Primary mouse dermal fibroblasts from heterozygous female X chromosome-linked GFP mice were sorted through FACS for GFP non-expressing cells (~50% of cells due to X-inactivation). The GFP- cells were treated with 4uM 5-aza-2'-deoxycytidine (5A2dC) for 48 hours with recovery in normal medium for 24 hours. Following the treatment, cells were again sorted by FACS into GFP-activated and GFP-nonexpressing cells. These populations, along with a control untreated population were assayed for transcriptional changes by microarray.

ORGANISM(S): Mus musculus

SUBMITTER: Bruce Lahn 

PROVIDER: E-MEXP-704 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Improved DNA methylation analysis via enrichment of demethylated cells expressing an X-inactivated transgene.

Vallender Tammy W TW   Lahn Bruce T BT  

BioTechniques 20061001 4


The demethylating drug 5-aza-2'-deoxycytidine (5-aza-2dC) is frequently used to investigate the effect of global DNA demethylation on gene expression in cultured mammalian cells. Here, we describe a method that uses the reactivation of an X-inactivated green fluorescent protein (GFP) transgene as a marker to enrich for cells that have undergone drug-induced demethylation. By combining it with microarray gene expression profiling, we demonstrate the method's utility in identifying genes activated  ...[more]

Similar Datasets

2008-06-13 | E-GEOD-4718 | biostudies-arrayexpress
2007-11-23 | E-GEOD-4768 | biostudies-arrayexpress
2007-11-23 | E-GEOD-4696 | biostudies-arrayexpress
2005-01-01 | E-MEXP-701 | biostudies-arrayexpress
2012-09-27 | E-GEOD-39915 | biostudies-arrayexpress
2012-09-11 | E-GEOD-39837 | biostudies-arrayexpress
2014-09-16 | GSE61415 | GEO
2013-01-16 | E-GEOD-43508 | biostudies-arrayexpress
| PRJNA291828 | ENA
2017-11-02 | PXD005812 | Pride